Cambridge Major Laboratories, Inc. Dedicates New Large-Scale Active Pharmaceutical Ingredient (API) Facility

Published: Jul 22, 2009

GERMANTOWN, Wis.--(BUSINESS WIRE)--Cambridge Major Laboratories (CML) announces it will be dedicating its new large scale Active Pharmaceutical Ingredient (API) manufacturing facility in Germantown, WI, USA on July 30, 2009. The state-of-the-art facility provides a high quality, US-based API supply option for the pharmaceutical and biotechnology industries, and is in response to CML’s need for larger capacity fueled by its growing pipeline of developmental and commercial manufacturing projects.

Back to news